Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001140361-25-016891
Filing Date
2025-05-01
Accepted
2025-05-01 15:33:30
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 11083
  Complete submission text file 0001140361-25-016891.txt   12658
Mailing Address 175 WEST JACKSON SUITE 340 CHICAGO IL 60604
Business Address 175 W. JACKSON SUITE 340 CHICAGO IL 60064 3128844400
WOLVERINE ASSET MANAGEMENT LLC (Filed by) CIK: 0001279891 (see all company filings)

EIN.: 020611276
Type: SCHEDULE 13G

Mailing Address 52 E 83RD ST. NEW YORK NY 10028
Business Address 52 E 83RD ST. NEW YORK NY 10028 (413) 204-2769
Translational Development Acquisition Corp. (Subject) CIK: 0001926599 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-94817 | Film No.: 25902464
SIC: 6770 Blank Checks
(CF Office: 05 Real Estate & Construction)